SQSTM1 and cancer: To address these gaps, we conducted a comprehensive pan-cancer analysis integrating The Cancer Genome Atlas (TCGA) multi-omics and immune-deconvolution datasets to delineate the associations of p62 with cancer-promoting pathways, immune suppression, anti-tumor immunity, and genomic instability.